Last reviewed · How we verify
Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines (H2H)
The purpose of the study is to provide preliminary comparative data on BoNT/A-DP versus Botox Cosmetic. Subsequently the sample size is primarily based on clinical judgement and practical considerations.
Details
| Lead sponsor | Croma-Pharma GmbH |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 208 |
| Start date | Wed Jun 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Frown Lines
Interventions
- Botulinum toxin A "BoNT/A-DP"
- Botulinum toxin A "Botox Cosmetics"
Countries
Austria, Canada, United States